Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. To continue reading ...

The Americans with Disabilities Act, landmark legislation enshrining civil rights for people with disabilities, was signed on ...

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared updates on its implantable glucose sensors.

WEDNESDAY, June 25, 2025 (HealthDay News) -- For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated with greater weight loss ...

All three doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40.

IBM Watson and the American Diabetes Association (ADA) will collaborate to create better disease management tools for those affected by diabetes. The project, unveiled at the ADA’s 76 th ...

The biotechnology company attended the American Diabetes Association meeting and presented new results from its UP421 cadaveric pancreatic islet cell program. The findings showed that people with ...

HealthDay News — The oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 weeks in adults with early type 2 diabetes, according ...

Kihealth, a leader in molecular diagnostics, today announced it has won the Innovation of the Year challenge at the American Diabetes Association’s 85 th Scientific Session held in Chicago. Kihealth’s ...

FluidForm Bio™ Presents Six-Month Efficacy Data of FRESH 3D Bioprinted Human Islet Subcutaneous Scaffolds at the American Diabetes Association (ADA) 85th Scientific Sessions ...

Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial.